2022
Association between plasma levels of BDNF and GDNF and the diagnosis, treatment response in first-episode MDD
Liu X, Li P, Ma X, Zhang J, Sun X, Luo X, Zhang Y. Association between plasma levels of BDNF and GDNF and the diagnosis, treatment response in first-episode MDD. Journal Of Affective Disorders 2022, 315: 190-197. PMID: 35908604, DOI: 10.1016/j.jad.2022.07.041.Peer-Reviewed Original ResearchMeSH KeywordsAntidepressive AgentsBrain-Derived Neurotrophic FactorDepressive Disorder, MajorGlial Cell Line-Derived Neurotrophic FactorHumansPrognosisConceptsAntidepressant treatmentPlasma levelsGDNF levelsMATRICS Consensus Cognitive BatteryMDD patientsHealthy controlsDepression severityWeeks antidepressant treatmentFirst-episode depressionPeripheral plasma levelsPeripheral venous bloodWeeks of treatmentDiagnosis of MDDDecreased plasma levelsHAMA-14Plasma BDNFAntidepressant medicationClinical symptomsHDRS-17Venous bloodCognitive dysfunctionPlasma concentrationsTreatment responseConsensus Cognitive BatteryPatients
2013
Health‐related quality of life and symptom severity in Chinese patients with major depressive disorder
Cao Y, Li W, Shen J, Malison RT, Zhang Y, Luo X. Health‐related quality of life and symptom severity in Chinese patients with major depressive disorder. Asia-Pacific Psychiatry 2013, 5: 276-283. PMID: 23857826, DOI: 10.1111/appy.12059.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAntidepressive AgentsAnxietyAsian PeopleChinaDepressive Disorder, MajorFemaleFluoxetineHealth StatusHumansMaleMiddle AgedOutcome Assessment, Health CarePsychiatric Status Rating ScalesQuality of LifeSeverity of Illness IndexSomatoform DisordersSurveys and QuestionnairesYoung Adult